🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
This randomized, cross over study aims to find out the benefits of deliveri...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-20
Trial ID
NCT03227445
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
Salt Bridging study for GSK961081...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-29
Trial ID
NCT00550225
Treatments Being Tested
The purpose of this study is to determine whether patients with asthma who ...
Status
Completed
Location
Maternal and Child Health Sciences, Ninewells Hospital and Medical School
Start Date
2007-08
Trial ID
NCT00655616
Treatments Being Tested
The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg ...
Status
Completed
Location
GSK Investigational Site
Start Date
2000-09
Trial ID
NCT00268216
Treatments Being Tested
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04-04
Trial ID
NCT01822899
COPD is characterized by an airflow limitation, which is not fully reversib...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-16
Trial ID
NCT03034915